BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 19885810)

  • 1. [Growth hormone and IGF-1 as doping agents in competitive sport].
    Jóźków P; Medraś M
    Endokrynol Pol; 2009; 60(5):389-94. PubMed ID: 19885810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-I abuse in sport.
    Guha N; Dashwood A; Thomas NJ; Skingle AJ; Sönksen PH; Holt RI
    Curr Drug Abuse Rev; 2009 Sep; 2(3):263-72. PubMed ID: 20443773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-I (IGF-I) misuse in athletes and potential methods for detection.
    Guha N; Cowan DA; Sönksen PH; Holt RI
    Anal Bioanal Chem; 2013 Dec; 405(30):9669-83. PubMed ID: 23934394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone, IGF-I and insulin and their abuse in sport.
    Holt RI; Sönksen PH
    Br J Pharmacol; 2008 Jun; 154(3):542-56. PubMed ID: 18376417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF-I abuse in sport: current knowledge and future prospects for detection.
    Guha N; Sönksen PH; Holt RI
    Growth Horm IGF Res; 2009 Aug; 19(4):408-11. PubMed ID: 19467615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demographic factors influencing the GH system: Implications for the detection of GH doping in sport.
    Nelson AE; Ho KK
    Growth Horm IGF Res; 2009 Aug; 19(4):327-32. PubMed ID: 19481485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum insulin-like growth factor-I and pro-collagen type III N-terminal peptide in adolescent elite athletes: implications for the detection of growth hormone abuse in sport.
    Guha N; Erotokritou-Mulligan I; Burford C; Strobridge G; Brigg J; Drake T; Bassett EE; Cowan D; Bartlett C; Sönksen PH; Holt RI
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2969-76. PubMed ID: 20410221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone in sports: detecting the doped or duped.
    Ho KK; Nelson AE
    Horm Res Paediatr; 2011; 76 Suppl 1():84-90. PubMed ID: 21778756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GH & IGF Research issue on doping with growth hormone.
    Sönksen PH; Holt RI
    Growth Horm IGF Res; 2009 Aug; 19(4):283-4. PubMed ID: 19535276
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin-like growth factor I and insulin and their abuse in sport.
    Erotokritou-Mulligan I; Holt RI
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):33-43, viii. PubMed ID: 20122448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of growth hormone (GH)-dependent markers in the detection of GH abuse in sport: Physiological intra-individual variation of IGF-I, type 3 pro-collagen (P-III-P) and the GH-2000 detection score.
    Erotokritou-Mulligan I; Eryl Bassett E; Cowan DA; Bartlett C; Milward P; Sartorio A; Sönksen PH; Holt RI
    Clin Endocrinol (Oxf); 2010 Apr; 72(4):520-6. PubMed ID: 19650783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-individual variation of GH-dependent markers in athletes: comparison of population based and individual thresholds for detection of GH abuse in sports.
    Kniess A; Ziegler E; Thieme D; Müller RK
    J Pharm Biomed Anal; 2013 Oct; 84():201-8. PubMed ID: 23850935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of insulin-like growth factor-1 in dried blood spots for detection of growth hormone abuse in sport.
    Cox HD; Rampton J; Eichner D
    Anal Bioanal Chem; 2013 Feb; 405(6):1949-58. PubMed ID: 23263515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone doping in sports: a critical review of use and detection strategies.
    Baumann GP
    Endocr Rev; 2012 Apr; 33(2):155-86. PubMed ID: 22368183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of hormones in doping and cancer risk.
    De Santi M; Baldelli G; Brandi G; ;
    Ann Ig; 2019; 31(6):590-594. PubMed ID: 31616903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can anabolic steroids or human growth hormone affect the growth and maturation of adolescent athletes?
    Rogol AD
    Pediatr Exerc Sci; 2014 Nov; 26(4):423-7. PubMed ID: 25372376
    [No Abstract]   [Full Text] [Related]  

  • 17. Statistical methodology for age-adjustment of the GH-2000 score detecting growth hormone misuse.
    Böhning D; Böhning W; Guha N; Cowan DA; Sönksen PH; Holt RI
    BMC Med Res Methodol; 2016 Oct; 16(1):147. PubMed ID: 27793179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of decision limits for the GH-2000 detection methodology using additional insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays.
    Holt RI; Böhning W; Guha N; Bartlett C; Cowan DA; Giraud S; Bassett EE; Sönksen PH; Böhning D
    Drug Test Anal; 2015 Sep; 7(9):745-55. PubMed ID: 25645199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doping in sport: effects, harm and misconceptions.
    Birzniece V
    Intern Med J; 2015 Mar; 45(3):239-48. PubMed ID: 25369881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker detection of rhGH doping: an excretion study.
    Jing J; Zhou X; He C; Zhang L; Yang S; Xu Y; Xie M; Yan Y; Su H; Wu M
    Drug Test Anal; 2012 Oct; 4(10):739-44. PubMed ID: 23074170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.